David Tuveson, MD, PhD

Dr. Tuveson is the Roy. J Zuckerberg Professor of Cancer Research at Cold Spring Harbor Laboratory (CSHL) in New York. He has served as director of CSHL’s Cancer Center since 2016, and he is chief scientist at the Lustgarten Foundation, a pancreatic cancer research organization. After completing a bachelor’s degree in chemistry at MIT, Dr. Tuveson received both his M.D. and Ph.D. from Johns Hopkins University in Baltimore. He completed a medical residency at Brigham and Women’s Hospital, a medical oncology fellowship at Dana-Farber/Partners Cancer Care, and a postdoctoral fellowship at MIT.

Dr. Tuveson’s laboratory was established first at the University of Pennsylvania and then at the University of Cambridge in the U.K., where he generated the first accurate mouse models of pancreatic cancer, which are now in widespread use. These mouse and more recent organoid models have been applied to fundamental and translational investigations including the prominent role of the tumor microenvironment in pancreatic cancer progression and drug resistance. In addition to his work at CSHL, Dr. Tuveson continues to practice medical oncology.

David Tuveson, MD, PhD headshot

Cygnal is a best-in-class team of biomedical experts and leaders collaborating to revolutionize how the world treats diseases.